Biography
Ann Livingstone is a research fellow, in the economics of cancer stream at Deakin Health Economics (DHE). She retrained as a health economist in 2016, after a career in cancer clinical trials, completing her PhD in 2022. Her PhD thesis investigated patient and clinician preferences for adjuvant immunotherapy as a treatment for melanoma skin cancer. Ann's research interests include exploring the trade-offs people are willing to make to access healthcare services and interventions. Her PhD used a Discrete Choice Experiment (DCE), a type of preference study, to inform and calculate the ‘value’ of cancer treatments to patients and clinicians. Ann has substantial expertise in consumer co-design, having worked closely with consumer groups throughout her career.
She has grant success as a Chief investigator on the NHMRC Centre of Research Excellence grant (Skin imaging and Precision diagnosis) and Cancer Australia grant, REZOLV3R: Randomised trial of palliative intraperitoneal bevacizumab following therapeutic drainage of recurrent malignant ascites in patients with chemotherapy-resistant solid tumours; and Associate Investigator on seven other NHMRC/Cancer Australia/Cancer Council grants.
Read more on Ann's profileResearch interests
Health Economics
Discrete Choice Experiments (DCE)
Preference elicitation for healthcare interventions
Teaching interests
Health Economics
Decision-making
Economic Evaluation
Knowledge areas
Health Economics
Discrete Choice Experiments (DCE)
Preference elicitation for healthcare interventions
Research groups
Economics of Cancer Stream
Publications
Ann Livingstone, April Murphy, Jessica Bucholc, Lidia Engel, Katherine Lane, Danielle Spence, Nikki McCaffrey
(2024), Vol. 14, pp. 1-5, BMJ Open, London, Eng., C1
Ann Livingstone, Kirsten Howard, Alexander Menzies, Georgina Long, Martin Stockler, Rachael Morton
(2023), The Patient - Patient-Centered Outcomes Research, Berlin, Germany, C1
N McCaffrey, J Bucholc, L Ng, K Chai, A Livingstone, A Murphy, L Gordon
(2023), Vol. 13, pp. e079052-, BMJ open, England, C1
D Addison, E Cheng, P Forrest, A Livingstone, R Morton, M Dennis
(2022), Vol. 178, pp. 19-25, Resuscitation, Ireland, C1
S Peters, J-L Pujol, U Dafni, M Dómine, S Popat, M Reck, J Andrade, A Becker, D Moro-Sibilot, A Curioni-Fontecedro, O Molinier, K Nackaerts, A Insa Mollá, R Gervais, G López Vivanco, J Madelaine, J Mazieres, M Faehling, F Griesinger, M Majem, J González Larriba, M Provencio Pulla, K Vervita, H Roschitzki-Voser, B Ruepp, P Mitchell, R Stahel, C Le Pechoux, D De Ruysscher, A Livingstone
(2022), Vol. 33, pp. 67-79, Annals of Oncology, Amsterdam, The Netherlands, C1-1
A Agarwal, A Livingstone, D Karikios, M Stockler, P Beale, R Morton
(2021), Vol. 21, pp. 1-10, BMC Cancer, Berlin, Germany, C1
Adjuvant immunotherapy recommendations for stage III melanoma: physician and nurse interviews
A Livingstone, K Dempsey, M Stockler, K Howard, G Long, M Carlino, A Menzies, R Morton
(2021), Vol. 21, pp. 1-9, BMC Cancer, Berlin, Germany, C1-1
A Livingstone, D Milne, K Dempsey, D Muscat, A Menzies, K Howard, M Stockler, R Morton
(2021), Vol. 14, pp. 635-647, Patient, Chester, Eng., C1-1
Preferences for Immunotherapy in Melanoma: A Systematic Review
A Livingstone, A Agarwal, M Stockler, A Menzies, K Howard, R Morton
(2020), Vol. 27, pp. 571-584, Annals of Surgical Oncology, Berlin, Germany, C1
A Livingstone, R Asaid, A Moaveni
(2019), Vol. 11, pp. 39-45, Shoulder and Elbow, London, Eng., C1-1
E Hovey, K Field, M Rosenthal, E Barnes, L Cher, A Nowak, H Wheeler, K Sawkins, A Livingstone, P Phal, C Goh, J Simes, P Kelly, A Hayden, E Barnes, D Espinoza, C Brown, D Winter, B Tomes, R Pike, J Simes, L Garrett, H Kilsby, R Freilich, I Arzhintar, A Dowling, N Ranieri, R Jennens, F Osmond, K Patterson, A Phay, A Byrne, S Begbie, P Williams, S Kirby-Lewis, F Abell, L Plowman, J Flynn, P Inglis, A Ives, S Lobb, Z Lwin, N Woodward, G Crosbie, N Singhal, S Smith, M Whelan
(2017), Vol. 4, pp. 171-181, Neuro-Oncology Practice, Oxford, Eng., C1-1
M Agar, E Koh, E Gibbs, E Barnes, E Hovey, A Livingstone, K Sawkins, R Chye, M Lovell, K Clark, J Vardy, M King
(2016), Vol. 24, pp. 1209-1218, Supportive Care in Cancer, Berlin, Germany, C1-1
Randomized phase 2 study of carboplatin and bevacizumab in recurrent glioblastoma
K Field, J Simes, A Nowak, L Cher, H Wheeler, E Hovey, C Brown, E Barnes, K Sawkins, A Livingstone, R Freilich, P Phal, G Fitt, M Rosenthal, I Arzhintar, L Garrett, A Byrne, A Dowling, N Ranieri, R Jennens, F Osmond, W Patterson, A Phay, F Abell, L Plowman, J Flynn, E Hovey, H Kilsby, S Kirby-Lewis, N Singhal, S Smith, M Whelan, P Inglis, A Ives, A Nowak, S Lobb, S Begbie, P Williams, Z Lwin, N Woodward, G Crosbie, R Harrup, L Pyszkowski, S Gauden, A Neville
(2015), Vol. 17, pp. 1504-1513, Neuro-Oncology, England, C1-1
Neuro-oncology practices in Australia: A Cooperative Group for Neuro-Oncology patterns of care study
J Chen, E Hovey, M Rosenthal, A Livingstone, J Simes
(2014), Vol. 10, pp. 162-167, Asia-Pacific Journal of Clinical Oncology, Australia, C1-1
Culturally and linguistically diverse patient participation in glioma research
Z Lwin, A Broom, R Cosman, A Livingstone, K Sawkins, P Good, E Kirby, E Koh, E Hovey
(2014), Vol. 1, pp. 101-105, Neuro-Oncology Practice, England, C1-1
Funded Projects at Deakin
No Funded Projects at Deakin found
Supervisions
No completed student supervisions to report